In the BioHarmony Drug Report Database
Deferasirox
Exjade, Jadenu, Jadenu Sprinkle (deferasirox) is a small molecule pharmaceutical. Deferasirox was first approved as Exjade on 2005-11-02. It is used to treat iron overload in the USA. It has been approved in Europe to treat beta-thalassemia and iron overload. Exjade’s patent is valid until 2034-11-21 (FDA).
Trade Name
|
Exjade |
|---|---|
Common Name
|
deferasirox |
ChEMBL ID
|
CHEMBL550348 |
Indication
|
beta-thalassemia, iron overload |
Drug Class
|
Image (chem structure or protein)